The Global Autoinjectors Market Size, Share & Growth Analysis By Therapy (Rheumatoid Arthritis, Multiple Sclerosis, Anaphylaxis, Diabetes, Other), By Type (Disposable, Reusable), By Route Of Administration (Subcutaneous, Intramuscular) By End-Use (Hospitals & Clinics, Ambulatory Surgical Centers, Home Care Settings), And Regional Forecast, 2021-2027, This research & consulting report doles out information about the global Autoinjectors market. The forecast period of the market extends till 2027, while commencing in 2020. The report sheds light on various key insights & trends that have occupied center stage & drawn the attention of end-users. The Autoinjectors industry is witnessing impressive expansion at present, having logged double digit CAGRs in the past.
The Global Autoinjectors Market was valued at USD 1,530.0 million in 2020, and is expected to reach USD 5,739.6 million by 2027, with a CAGR of 18.1% during the forecast period.
The report alludes to the Autoinjectors market as a lucrative sector. This sector is slated to generate substantial revenues during forecast period 2021 to 2027. The analytical report highlights data & overview regarding the size, shares, & demand of Autoinjectors. Several other factors have had a positive or negative impact on the industry, all of which have been laid out in details.
The said factors comprise drivers, novel prospects, hindrances, and other vital characteristics of the market. Investments by rivals into Autoinjectors products have catapulted the market into limelight & have stoked its demand, globally.
Few among other key aspects that find a mention; encompass the industry segments, predictions, & size and shares for 2021 to 2027. Besides these; the report narrows down on the innovative trends & technological developments, expansion strategies of key players, and regional statistics.
The manner in which nascent & local competitors stack up against prominent players, hogs the spotlight. Novel products & services, coupled with the monetary shares of eminent competitors and the SWOT analysis unveil the complexities of the global industry size.
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends from 2021 to 2027 in each of the sub segments. For the purpose of this study, Eternity Insights has segmented the global Autoinjectors market on the basis of therapy, type, administration, end-use and region:
Research methodology is an integral component of any kind of high-level market research. It entails evaluation by expert panels, research on secondary & primary levels, checks on quality, & testing on completion. Secondary research deeply focuses on the whys, whos, wheres, whens, & hows and caters to answering the strictly consumer-centric base of people.
Some other secondary research sources comprise governmental affiliations & blogs, business magazines, and industrial journals. Primary research includes face-to-face & telephonic interviews with industry experts. It is comparatively more detailed & lays stress on unprejudiced opinions about the products & services.
Primary research findings cement secondary research & help end-users & businesses get a better hang of various markets. It is a well-established fact, though, that research methodology is best implemented through the mixed execution of its aforementioned procedures.
What Does the Report Offer?
Other Vital Points That Are Covered
The market report also brings to light major opportunities and untapped geographies. It is more like a blend of customized research documents & conventional reports. Besides informing buyers about the pros & cons of direct and indirect sales channels, the analysis exhibits illustrations & graphical representations of industry growth and the innovative trends within the industry.
Table of Content
Chapter 1. Methodology & Sources
1.1. Market Definition
1.2. Research Scope
1.3. Methodology
1.4. Research Sources
1.4.1. Primary
1.4.2. Secondary
1.4.3. Paid Sources
1.5. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2017-2027
Chapter 3. Key Insights
Chapter 4. Global Autoinjectors Market Segmentation & Impact Analysis
4.1. Global Autoinjectors Market Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Major prevalence of diabetes
4.2.2.2. Growing global geriatric population
4.2.3. Market restraints analysis
4.2.3.1. High cost of autoinjectors devices
4.2.3.2. Availability of alternative drug delivery methods
4.3. Technological Insights
4.4. Regulatory Framework
4.5. Porter’s Five Forces Analysis
4.6. Competitive Metric Space Analysis
4.7. Price trend Analysis
4.8. Covid-19 Impact Analysis
Chapter 5. Global Autoinjectors Market Therapy Insights & Trends, Revenue (USD Billion)
5.1. Therapy Dynamics & Market Share, 2017 & 2027
5.1.1. Rheumatoid Arthritis
5.1.2. Multiple Sclerosis
5.1.3. Anaphylaxis
5.1.4. Diabetes
5.1.5. Others
Chapter 6. Global Autoinjectors Market Type Insights & Trends, Revenue (USD Billion)
6.1. Type Dynamics & Market Share, 2017 & 2027
6.1.1. Disposable
6.1.2. Reusable
Chapter 7. Global Autoinjectors Market Route of Administration Insights & Trends, Revenue (USD Billion)
7.1. Route of Administration Dynamics & Market Share, 2017 & 2027
7.1.1. Subcutaneous
7.1.2. Intramuscular
Chapter 8. Global Autoinjectors Market End-Use Insights & Trends Revenue (USD Billion)
8.1. End-Use Dynamics & Market Share, 2017 & 2027
8.1.1. Hospitals & Clinics
8.1.2. Ambulatory Surgical Centers
8.1.3. Home Care Settings
Chapter 9. Global Autoinjectors Market Regional Outlook
9.1. Global Autoinjectors Market share By Region, 2017 & 2027
9.2. North America
9.2.1. Global Autoinjectors Market By Therapy, Market Estimates and Forecast, (USD Billion)
9.2.1.1. Rheumatoid Arthritis
9.2.1.2. Multiple Sclerosis
9.2.1.3. Anaphylaxis
9.2.1.4. Diabetes
9.2.1.5. Others
9.2.2. Global Autoinjectors Market By Type, Market Estimates and Forecast, (USD Billion)
9.2.2.1. Disposable
9.2.2.2. Reusable
9.2.3. Global Autoinjectors Market By Route of Administration, Market Estimates and Forecast, (USD Billion)
9.2.3.1. Subcutaneous
9.2.3.2. Intramuscular
9.2.4. Global Autoinjectors Market By End-Use, Estimates and Forecast, (USD Billion)
9.2.4.1. Hospitals & Clinics
9.2.4.2. Ambulatory Surgical Centers
9.2.4.3. Home Care Settings
9.2.5. Global Autoinjectors Market By Country, Estimates and Forecast, (USD Billion)
9.2.5.1. U.S.
9.2.5.2. Canada
9.2.5.3. Mexico
9.3. Europe
9.3.1. Global Autoinjectors Market By Therapy, Market Estimates and Forecast, (USD Billion)
9.3.1.1. Operating Microscopes
9.3.1.2. Micro Forceps
9.3.1.3. Micro Scissors
9.3.1.4. Micro Sutures
9.3.1.5. Microsurgery Needle Holders
9.3.1.6. Others
9.3.2. Global Autoinjectors Market By Type, Estimates and Forecast, (USD Billion)
9.3.2.1. Disposable
9.3.2.2. Reusable
9.3.3. Global Autoinjectors Market By Route of Administration, Estimates and Forecast, (USD Billion)
9.3.3.1. Subcutaneous
9.3.3.2. Intramuscular
9.3.4. Global Autoinjectors Market By End-Use, Estimates and Forecast, (USD Billion)
9.3.4.1. Hospitals & Clinics
9.3.4.2. Ambulatory Surgical Centers
9.3.4.3. Home Care Settings
9.3.5. Market By Country, Estimates and Forecast, (USD Billion)
9.3.5.1. Germany
9.3.5.2. France
9.3.5.3. U.K.
9.3.5.4. BENELUX
9.3.5.5. Italy
9.3.5.6. Spain
9.3.5.7. Switzerland
9.3.5.8. Russia
9.3.5.9. Rest of Europe
9.4. Asia Pacific
9.4.1. Global Autoinjectors Market By Therapy, Market Estimates and Forecast, (USD Billion)
9.4.1.1. Rheumatoid Arthritis
9.4.1.2. Multiple Sclerosis
9.4.1.3. Anaphylaxis
9.4.1.4. Diabetes
9.4.1.5. Others
9.4.2. Global Autoinjectors Market By Type, Market Estimates and Forecast, (USD Billion)
9.4.2.1. Disposable
9.4.2.2. Reusable
9.4.3. Global Autoinjectors Market By End-Use, Estimates and Forecast, (USD Billion)
9.4.3.1. Hospitals & Clinics
9.4.3.2. Ambulatory Surgical Centers
9.4.3.3. Home Care Settings
9.4.4. Market By Country, Estimates and Forecast, (USD Billion)
9.4.4.1. China
9.4.4.2. Japan
9.4.4.3. South Korea
9.4.4.4. India
9.4.4.5. Rest of APAC
9.5. Latin America
9.5.1. Global Autoinjectors Market By Therapy, Market Estimates and Forecast, (USD Billion)
9.5.1.1. Rheumatoid Arthritis
9.5.1.2. Multiple Sclerosis
9.5.1.3. Anaphylaxis
9.5.1.4. Diabetes
9.5.1.5. Others
9.5.2. Global Autoinjectors Market By Type, Market Estimates and Forecast, (USD Billion)
9.5.2.1. Rheumatoid Arthritis
9.5.2.2. Multiple Sclerosis
9.5.2.3. Anaphylaxis
9.5.2.4. Diabetes
9.5.2.5. Others
9.5.3. Global Autoinjectors Market By Route of Administration, Market Estimates and Forecast, (USD Billion)
9.5.3.1. Subcutaneous
9.5.3.2. Intramuscular
9.5.4. Global Autoinjectors Market By End-Use, Estimates and Forecast, (USD Billion)
9.5.4.1. Hospitals & Clinics
9.5.4.2. Ambulatory Surgical Centers
9.5.4.3. Home Care Settings
9.5.5. Market By Country, Estimates and Forecast, (USD Billion)
9.5.5.1. Brazil
9.5.5.2. Rest of LATAM
9.6. Middle East & Africa
9.6.1. Global Autoinjectors Market By Therapy, Market Estimates and Forecast, (USD Billion)
9.6.1.1. Rheumatoid Arthritis
9.6.1.2. Multiple Sclerosis
9.6.1.3. Anaphylaxis
9.6.1.4. Diabetes
9.6.1.5. Others
9.6.2. Global Autoinjectors Market By Type, Market Estimates and Forecast, (USD Billion)
9.6.2.1. Disposable
9.6.2.2. Reusable
9.6.3. Global Autoinjectors Market By Route of Administration, Market Estimates and Forecast, (USD Billion)
9.6.3.1. Subcutaneous
9.6.3.2. Intramuscular
9.6.4. Global Autoinjectors Market By End-Use, Estimates and Forecast, (USD Billion)
9.6.4.1. Hospitals & Clinics
9.6.4.2. Ambulatory Surgical Centers
9.6.4.3. Home Care Settings
9.6.5. Market By Country, Estimates and Forecast, (USD Billion)
9.6.5.1. Saudi Arabia
9.6.5.2. UAE
9.6.5.3. South Africa
9.6.5.4. Turkey
9.6.5.5. Rest of MEA
Chapter 10. Competitive Landscape
10.1. Market Revenue Share By Manufacturers
10.2. Mergers & Acquisitions
10.3. Competitor’s Positioning
10.4. Strategy Benchmarking
10.5. Suppliers Landscape
10.6. Raw Material suppliers
10.6.1. North America
10.6.2. Europe
10.6.3. Asia Pacific
10.6.4. Middle East & Africa
10.6.5. Latin America
10.7. Service Providers
10.7.1. North America
10.7.2. Europe
10.7.3. Asia Pacific
10.7.4. Middle East & Africa
10.7.5. Latin America
10.7.6. Others
Chapter 11. Company Profiles
11.1. B. Braun Melsungen AG
11.1.1. Company Overview
11.1.2. Financial Performance
11.1.3. Technology Insights
11.1.4. Strategic Initiatives
11.1.5. Eternity Insights
11.2. AbbVie Inc.
11.2.1. Company Overview
11.2.2. Financial Performance
11.2.3. Technology Insights
11.2.4. Strategic Initiatives
11.2.5. Eternity Insights
11.3. Mylan
11.3.1. Company Overview
11.3.2. Financial Performance
11.3.3. Technology Insights
11.3.4. Strategic Initiatives
11.3.5. Eternity Insights
11.4. Eli Lilly and Company
11.4.1. Company Overview
11.4.2. Financial Performance
11.4.3. Technology Insights
11.4.4. Strategic Initiatives
11.4.5. Eternity Insights
11.5. Ypsomed
11.5.1. Company Overview
11.5.2. Financial Performance
11.5.3. Technology Insights
11.5.4. Strategic Initiatives
11.5.5. Eternity Insights
11.6. Amgen
11.6.1. Company Overview
11.6.2. Financial Performance
11.6.3. Technology Insights
11.6.4. Strategic Initiatives
11.6.5. Eternity Insights
11.7. Becton, Dickinson and Company
11.7.1. Company Overview
11.7.2. Financial Performance
11.7.3. Technology Insights
11.7.4. Strategic Initiatives
11.7.5. Eternity Insights
11.8. GlaxoSmithKline plc
11.8.1. Company Overview
11.8.2. Financial Performance
11.8.3. Technology Insights
11.8.4. Strategic Initiatives
11.8.5. Eternity Insights
11.9. Johnson & Johnson
11.9.1. Company Overview
11.9.2. Financial Performance
11.9.3. Technology Insights
11.9.4. Strategic Initiatives
11.9.5. Eternity Insights
11.10. Antares Pharma
11.10.1. Company Overview
11.10.2. Financial Performance
11.10.3. Technology Insights
11.10.4. Strategic Initiatives
11.10.5. Eternity Insights
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
A faster and efficient way to cater to the needs with continuous iteration
Focus on Data Accuracy & Reliability
75+ Clients in Fortune 500
All your transactions are secured end-to-end, ensuring a satisfactory purchase
Ensure the best and affordable pricing
